APC anti-mouse CD11c Antibody

Pricing & Availability
Clone
N418 (See other available formats)
Regulatory Status
RUO
Other Names
αX integrin, integrin αX chain, CR4, p150, ITGAX
Isotype
Armenian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
N418
C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
  • N418
    C57BL/6 mouse splenocytes stained with N418 APC and PK136 PE
Compare all formats See APC spectral data
Cat # Size Price Quantity Check Availability Save
117309 25 µg 54€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
117310 100 µg 186€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11c is a 150 kD glycoprotein also known as αX integrin, CR4, and p150. CD11c forms a αXβ2 heterodimer with β2 integrin (CD18). It is primarily expressed on dendritic cells, NK cells, a subset of intestinal intraepithelial lymphocytes (IEL), and some activated T cells. The αXβ2 integrin plays an important role in cell-cell contact by binding its ligands: iC3b, fibrinogen, and CD54.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Armenian Hamster
Immunogen
Mouse spleen dendritic cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD11c antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation3, immunohistochemical staining of acetone-fixed frozen sections3, immunofluorescence microscopy5, 9 (Alexa Fluor® 488 conjugated N418 was used for IHC in frozen sections10), and spatial biology (IBEX)22,23.

Application References

(PubMed link indicates BioLegend citation)
  1. Granucci F, et al. 1997. J. Immunol. 159:1794.
  2. Stokes RW, et al. 1998. J. Immunol. 160:5514.
  3. Metlay JP, et al. 1990. J. Exp. Med. 171:1753. (IHC, IP)
  4. Ma XT, et al. 2006. Cancer Research 66:1169.
  5. Chin RK, et al. 2006. J. Immunol. 177:290. (IF)
  6. Cervantes-Barragan L, et al. 2007. Blood 109:1131. (FC) PubMed
  7. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC) PubMed
  8. Benson MJ, et al. 2007. J. Exp. Med. doi:10.1084/jem.20070719. (FC) PubMed
  9. You Y, et al. 2009. J. Immunol. 182:7343. (IF) PubMed
  10. Roland CL, et al. 2009. Mol. Cancer Res. 8:1761. (IHC, FC) PubMed
  11. Wikstrom M, et al.2006. J. Immunol. 177:913. PubMed
  12. Pericolini E, et al. 2008. J. Leukocyte Biol. 83:1286. PubMed
  13. Randall LM, et al. 2008. Infect. Immun.76:3312. PubMed
  14. Fahlen-Yrild L, et al. 2009. J. Immunol. 183:5032. PubMed
  15. Osterholzer JJ, et al. 2009. J. Immunol. 183:8044. PubMed
  16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
  17. Eisenach PA, et al. 2010. J Cell Sci. 123:4182. PubMed
  18. Leppin K, et al. 2014. Invest. Ophthalmol. Vis. Sci. 55:3603. PubMed
  19. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  20. Gibbins JD, et al. 2014. Blood. 124:2953. PubMed
  21. White CE, et al. 2015. J Immunol. 194:697. PubMed
  22. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  23. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  24. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gentschev I, et al. 2012. PLoS One. 7:e37239. PubMed
  2. Berthold N, et al. 2013. Antimicrob Agents Chemother. 57:402. PubMed
  3. Riva A, et al. 2013. J Immunol. 190:5961. PubMed
  4. Bak S, et al. 2008. Mol Immunol. 45:1414. PubMed
  5. Glauser D, et al. 2013. J Virol. 87:10828. PubMed
  6. Takaki H, et al. 2013. J Immunol. 191:4740. PubMed
  7. Zhao W, et al. 2014. Clin Vaccine Immunol. 21:74. PubMed
  8. Prado C, et al. 2012. J Immunol. 188:3062. PubMed
  9. Ustarroz-Cano M, et al. 2012. J Immunotoxicol. 9:374. PubMed
  10. Bunn P, et al. 2014. J Immunol. 192:3709. PubMed
  11. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  12. Xia S, et al. 2014. J Leukoc Biol. 95:733. PubMed
  13. Markey K, et al. 2014. J Immunol. 192:5426. PubMed
  14. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  15. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  16. Sakai F, et al. 2014. PLoS One. 9:105370. PubMed
  17. Gibbins J, et al. 2014. Blood. 124:2953. PubMed
  18. White C, et al. 2015. J Immunol. 194:697. PubMed
  19. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  20. Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
  21. Qian F, et al. 2015. J Mol Cell Biol. . PubMed
  22. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  23. Wegmann F, et al. 2015. Clin Vaccine Immunol. 22: 1004-1012. PubMed
  24. Tozuka M, et al. 2016. J Dermatol Sci. 82: 38-45. PubMed
  25. Spinner C, et al. 2015. Sci Rep. 5:16269. PubMed
  26. Mainini F, et al. 2015. PLoS One. 10: 0145403. PubMed
  27. Montes de Oca M, et al. 2016. PLoS Pathog. 12: 1005398. PubMed
  28. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  29. Pelly V, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.4. PubMed
  30. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  31. Peng X, et al. 2016. J Cell Sci. 129: 1831 - 1842. PubMed
  32. Upadhya R, et al. 2016. MBio. 7: 00547-16. PubMed
  33. Sellau J, et al. 2016. Sci Rep. 6:28058. PubMed
  34. Coppo M, et al. 2016. Nat Commun. 7:12254. PubMed
  35. Gujar R, et al. 2016. J Immunol. 197: 1650 - 1662. PubMed
  36. Hrdinka M, et al. 2016. PLoS One. 11: 0162863. PubMed
  37. Martins R, et al. 2016. Nat Immunol. 17:1361-1372. PubMed
  38. Sebina I, et al. 2016. PLoS Pathog. 12:e1005999. PubMed
  39. Liu M, et al. 2016. PLoS One. 11:e0166165. PubMed
  40. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  41. O'Shea NR, Chew TS 2016. J Crohns Colitis. 10(12):1417-1427. PubMed
  42. Aguilera T, et al. 2016. Nat Commun. 7:13898. PubMed
  43. Cerina M, et al. 2017. Brain Behav Immun. 59:103-117. PubMed
  44. Kramer K, et al. 2017. Mol Ther. 25(1):62-70. PubMed
  45. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  46. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  47. Wanner-Seleznik GM, et al. 2020. Immunohorizons. 0.644444444. PubMed
  48. Cortez MA, et al. 2020. Nat Commun. 3.819444444. PubMed
  49. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  50. Miller CM, et al. 2020. J Virol. 94:00:00. PubMed
  51. Dobson HE, et al. 2020. Mucosal Immunol. 0.901388889. PubMed
  52. Aguilera TA, et al. 2020. Clin Cancer Res. 26:2972. PubMed
  53. Wang Y, et al. 2021. Sci Rep. 1.429861111. PubMed
  54. Wang Y, et al. 2021. Nat Commun. 0.570833333. PubMed
  55. Li N, et al. 2021. eLife. 10:00. PubMed
  56. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  57. Liu Z, et al. 2021. Immunity. 54(2):247-258.e7. PubMed
  58. Han C, et al. 2021. Cell Reports. 34(6):108706. PubMed
  59. Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
  60. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  61. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  62. de Mingo Pulido , et al. 2021. Immunity. 54(6):1154-1167.e7. PubMed
  63. Ye Y, et al. 2017. Sci Immunol. 2:17. PubMed
  64. Platteel A, et al. 2017. Vaccine.. 10.1016/j.vaccine.2017.10.044. PubMed
  65. Chu LH, et al. 2018. Nat Commun. 9:996. PubMed
  66. Miteva K, et al. 2018. Sci Rep. 8:2820. PubMed
  67. Oyarce C, et al. 2018. Front Immunol. 8:1794. PubMed
  68. Sharma PK, et al. 2018. Cancer Gene Ther. 25:27. PubMed
  69. Nam GH, et al. 2018. Nat Commun. 9:2165. PubMed
  70. Emgård J, et al. 2018. Immunity. 143:419. PubMed
  71. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  72. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  73. Xia P et al. 2018. Immunity. 48(4):688-701 . PubMed
  74. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  75. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  76. Fujita Y et al. 2018. Cell reports. 24(12):3296-3311 . PubMed
  77. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  78. Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed
  79. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  80. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  81. Dyer DP et al. 2019. Immunity. 50(2):378-389 . PubMed
  82. Zhao J, et al. 2019. Nat Commun. 10:899. PubMed
  83. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  84. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  85. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  86. Zeng J, et al. 2018. J Immunol. 200:3407. PubMed
  87. Niknam S, et al. 2018. Clin Cancer Res. 24:5735. PubMed
  88. Trinh HKT, et al. 2019. J Cell Mol Med. 23:3441. PubMed
  89. Agelidis A, et al. 2019. Front Immunol. 10:500. PubMed
  90. Matsumura T et al. 2019. Cell Rep. 27(2):561-571 . PubMed
  91. Ramakrishna C, et al. 2019. Nat Commun. 10:2153. PubMed
  92. Hu J, et al. 2019. Mol Ther Nucleic Acids. 16:650. PubMed
  93. Kubli SP, et al. 2019. Nat Commun. 10:2678. PubMed
  94. Li C, et al. 2018. Cell. 174:285. PubMed
  95. Page N, et al. 2018. Immunity. 48:937. PubMed
  96. Budida R, et al. 2017. Eur J Immunol. 47:1819. PubMed
  97. He J, et al. 2019. J Clin Invest. 130. PubMed
  98. Wang C, et al. 2018. Sci Transl Med. 10. PubMed
  99. Lin SY, et al. 2017. Autophagy. 14:778. PubMed
  100. Yamada S, et al. 2018. Arterioscler Thromb Vasc Biol. 38:994. PubMed
  101. Kim TJ, et al. 2019. Nat Commun. 10:3258. PubMed
  102. Kemp V, et al. 2018. Cancer Gene Ther. 26:268. PubMed
  103. Takeda Y, et al. 2018. Innate Immun. 24:323. PubMed
  104. Shi L, et al. 2019. Theranostics. 9:4115. PubMed
  105. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  106. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  107. Nagashima H et al. 2019. Immunity. 51(4):682-695 . PubMed
  108. Liu D et al. 2019. Immunity. 51(1):64-76 . PubMed
  109. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  110. Sparber F, et al. 2019. Cell Host Microbe. 25:389. PubMed
  111. Shin M et al. 2019. Cell Chem Biol. 26(7):1036-1041 . PubMed
  112. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  113. Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
  114. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  115. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  116. Morrissey MA, et al. 2018. Elife. 7:e36688. PubMed
  117. Gu H, et al. 2018. Aging (Albany NY). 1.525694444. PubMed
  118. Kramer K, et al. 2017. ACS Omega. 0.240972222. PubMed
  119. Matisz CE, et al. 2018. Am J Pathol. 188:2589. PubMed
  120. Liu W, et al. 2019. Epigenetics. 1.192361111. PubMed
  121. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  122. Yahagi A, et al. 2019. RMD Open. 5:e000853. PubMed
  123. Tomida S, et al. 2019. Sci Rep. 9:10751. PubMed
  124. Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed
  125. Wang S, et al. 2020. J Cell Mol Med. 24:722. PubMed
  126. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  127. Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
  128. Li Y, et al. 2020. Cell Rep. 30:1753. PubMed
  129. Kunishita Y, et al. 2020. Front Immunol. 11:98. PubMed
  130. Brenner E, et al. 2020. Nat Commun. 11:1335. PubMed
  131. Huang WC, et al. 2020. NPJ Vaccines. 5:23. PubMed
  132. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  133. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  134. Kawabe T, et al. 2020. Nat Commun. 2.795833333. PubMed
  135. Lisk C, et al. 2020. Front Immunol. 1.329166667. PubMed
  136. Cheng Y, et al. 2020. PLoS Pathog. 16:e1008569. PubMed
  137. McCauley ME, et al. 2020. Nature. 585(7823):96-101. PubMed
  138. Bode K, et al. 2020. Cell Reports. 29(13):4435-4446.e9.. PubMed
  139. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  140. Chitu V, et al. 2020. Cell Reports. 30(9):3004-3019. PubMed
  141. Blumenthal D, et al. 2020. eLife. 9:e55995.. PubMed
  142. Kunimura K, et al. 2020. Cell Reports. 29(9):2823-2834.e7.. PubMed
  143. Xu H, et al. 2020. Immunity. 51(4):696-708.e9.. PubMed
  144. He Y, et al. 2020. Sci Adv. 6:eaba7589. PubMed
  145. Bertino P, et al. 2019. Oncoimmunology. 8:1601482. PubMed
  146. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  147. Marsh L, et al. 2009. Am J Physiol Lung Cell Mol Physiol. 296:L442. PubMed
RRID
AB_313778 (BioLegend Cat. No. 117309)
AB_313779 (BioLegend Cat. No. 117310)

Antigen Details

Structure
Integrin α-chain, associates with integrin β2 (CD18), 150 kD
Distribution

Dendritic cells, NK cells, intestinal intraepithelial lymphocytes (IEL), some activated T cells

Function
Cellular adhesion
Ligand/Receptor
iC3b, fibrinogen
Cell Type
Dendritic cells, Epithelial cells, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen Facts Book Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Lopez-Rodriguez C, et al. 1996. J. Immunol. 156:3780.

Gene ID
16411 View all products for this Gene ID
UniProt
View information about CD11c on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11c Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD11c N418 FC
Biotin anti-mouse CD11c N418 FC, IHC-F
FITC anti-mouse CD11c N418 FC
PE anti-mouse CD11c N418 FC
Purified anti-mouse CD11c N418 FC, CyTOF®, IP, IHC
Alexa Fluor® 488 anti-mouse CD11c N418 FC
Alexa Fluor® 647 anti-mouse CD11c N418 FC, IHC, ICC, 3D IHC
PE/Cyanine5 anti-mouse CD11c N418 FC
PE/Cyanine7 anti-mouse CD11c N418 FC
Brilliant Violet 605™ anti-mouse CD11c N418 FC
Alexa Fluor® 700 anti-mouse CD11c N418 FC
Pacific Blue™ anti-mouse CD11c N418 FC
APC/Cyanine7 anti-mouse CD11c N418 FC
PerCP/Cyanine5.5 anti-mouse CD11c N418 FC
PerCP anti-mouse CD11c N418 FC
Brilliant Violet 421™ anti-mouse CD11c N418 FC, IHC
Brilliant Violet 570™ anti-mouse CD11c N418 FC
Brilliant Violet 785™ anti-mouse CD11c N418 FC
Brilliant Violet 510™ anti-mouse CD11c N418 FC
Brilliant Violet 650™ anti-mouse CD11c N418 FC
Purified anti-mouse CD11c (Maxpar® Ready) N418 FC, CyTOF®
Alexa Fluor® 594 anti-mouse CD11c N418 IHC-F, 3D IHC
PE/Dazzle™ 594 anti-mouse CD11c N418 FC
Brilliant Violet 711™ anti-mouse CD11c N418 FC
APC/Fire™ 750 anti-mouse CD11c N418 FC
TotalSeq™-A0106 anti-mouse CD11c N418 PG
Brilliant Violet 750™ anti-mouse CD11c N418 FC
TotalSeq™-B0106 anti-mouse CD11c N418 PG
TotalSeq™-C0106 anti-mouse CD11c N418 PG
KIRAVIA Blue 520™ anti-mouse CD11c N418 FC
Spark Blue™ 550 anti-mouse CD11c N418 FC
Spark NIR™ 685 anti-mouse CD11c N418 FC
Spark UV™ 387 anti-mouse CD11c N418 FC
Spark Red™ 718 anti-mouse CD11c N418 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD11c

  • Biotin anti-mouse CD11c

  • FITC anti-mouse CD11c

  • PE anti-mouse CD11c

  • Purified anti-mouse CD11c

  • Alexa Fluor® 488 anti-mouse CD11c

  • Alexa Fluor® 647 anti-mouse CD11c

  • PE/Cyanine5 anti-mouse CD11c

  • PE/Cyanine7 anti-mouse CD11c

  • Brilliant Violet 605™ anti-mouse CD11c

  • Alexa Fluor® 700 anti-mouse CD11c

  • Pacific Blue™ anti-mouse CD11c

  • APC/Cyanine7 anti-mouse CD11c

  • PerCP/Cyanine5.5 anti-mouse CD11c

  • PerCP anti-mouse CD11c

  • Brilliant Violet 421™ anti-mouse CD11c

  • Brilliant Violet 570™ anti-mouse CD11c

  • Brilliant Violet 785™ anti-mouse CD11c

  • Brilliant Violet 510™ anti-mouse CD11c

  • Brilliant Violet 650™ anti-mouse CD11c

  • Purified anti-mouse CD11c (Maxpar® Ready)

  • Alexa Fluor® 594 anti-mouse CD11c

  • PE/Dazzle™ 594 anti-mouse CD11c

  • Brilliant Violet 711™ anti-mouse CD11c

  • APC/Fire™ 750 anti-mouse CD11c

  • TotalSeq™-A0106 anti-mouse CD11c

  • Brilliant Violet 750™ anti-mouse CD11c

  • TotalSeq™-B0106 anti-mouse CD11c

  • TotalSeq™-C0106 anti-mouse CD11c

  • KIRAVIA Blue 520™ anti-mouse CD11c

  • Spark Blue™ 550 anti-mouse CD11c

  • Spark NIR™ 685 anti-mouse CD11c

  • Spark UV™ 387 anti-mouse CD11c

  • Spark Red™ 718 anti-mouse CD11c

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account